Use of third-line therapies in advanced sarcoidosis.
CONCLUSIONS: While third-line therapies are often initially effective, a significant number of patients discontinued individual treatments and initiated an alternative third-line therapy.
PMID: 31820728 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Allergy & Immunology | Brain | Humira | Neurology | Remicade | Rheumatology | Rituxan | Sarcoidosis